Earnings Feed
Start Free
Theravance Biopharma, Inc.·4

Feb 24, 7:07 PM ET

HAUMANN BRETT K 4

4 · Theravance Biopharma, Inc. · Filed Feb 24, 2020

Insider Transaction Report

Form 4
Period: 2020-02-20
Theravance Biopharma, Inc.TBPH
HAUMANN BRETT K
SVP, Clinical Development
Transactions
  • Tax Payment

    Ordinary Shares

    2020-02-20$25.90/sh−33,608$870,447→ 316,668 total

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -